Cargando…

Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease

Aberrant α-synuclein (α-Syn) accumulation resulting from proteasome dysfunction is considered as a prominent factor to initiate and aggravate the neurodegeneration in Parkinson's disease (PD). Although the involvement of 26S proteasome in proteostasis imbalance has been widely accepted, our kno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Mingxia, Du, Xixun, Xiao, Xue, Dai, Yingying, Jiao, Qian, Chen, Xi, Zhang, Lingqiang, Jiang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577461/ https://www.ncbi.nlm.nih.gov/pubmed/34662812 http://dx.doi.org/10.1016/j.redox.2021.102167

Ejemplares similares

Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown
por: Bi, Mingxia, et al.
Publicado: (2021)

Potential Crosstalk Between Parkinson's Disease and Energy Metabolism
por: Liu, Meiqiu, et al.
Publicado: (2021)

Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson’s Disease Models
por: Bi, Mingxia, et al.
Publicado: (2018)

Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection via Activation of Immunoproteasome
por: Zhou, Hefeng, et al.
Publicado: (2019)

Investigation of Behavioral Dysfunctions Induced by Monoamine Depletions in a Mouse Model of Parkinson's Disease
por: Li, Yong, et al.
Publicado: (2018)

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders
por: Ugras, Scott, et al.
Publicado: (2018)

Corneal Wound Healing Is Compromised by Immunoproteasome Deficiency
por: Ferrington, Deborah A., et al.
Publicado: (2013)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice
por: Farini, A., et al.
Publicado: (2022)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
por: Wang, Rui, et al.
Publicado: (2022)

Immunoproteasome Deficiency Protects in the Retina after Optic Nerve Crush
por: Schuld, Nathan J., et al.
Publicado: (2015)

Investigating AKT activation and autophagy in immunoproteasome-deficient retinal cells
por: Karim, Md. Razaul, et al.
Publicado: (2020)

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
por: Besse, Andrej, et al.
Publicado: (2022)

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
por: van den Berge, Simone A., et al.
Publicado: (2012)

Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022)

Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
por: Yang, Yunseon, et al.
Publicado: (2022)

Immunoproteasome Deficiency Modifies the Alternative Pathway of NFκB Signaling
por: Maldonado, Marcela, et al.
Publicado: (2013)

Immunoproteasome subunit LMP7 Deficiency Improves Obesity and Metabolic Disorders
por: Kimura, Hiroaki, et al.
Publicado: (2015)

Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis
por: Hewing, Bernd, et al.
Publicado: (2017)

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
por: Flønes, Irene Hana, et al.
Publicado: (2022)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson’s disease
por: Yan, Mingmin, et al.
Publicado: (2022)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits
por: Griffin, Thomas A., et al.
Publicado: (1998)

Regulation of Immunoproteasome Function in the Lung
por: Keller, Ilona E., et al.
Publicado: (2015)

Dysfunctional immunoproteasomes in autoinflammatory diseases
por: Arimochi, Hideki, et al.
Publicado: (2016)

On the Role of the Immunoproteasome in Protein Homeostasis
por: Basler, Michael, et al.
Publicado: (2021)

The Function of Immunoproteasomes—An Immunologists’ Perspective
por: van den Eshof, Bart L., et al.
Publicado: (2021)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
por: Zaltieri, Michela, et al.
Publicado: (2015)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
por: Raiss, Christian C., et al.
Publicado: (2016)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Identifying the potential genes in alpha synuclein driving ferroptosis of Parkinson’s disease
por: Wang, Min, et al.
Publicado: (2023)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease
por: Cersosimo, Maria Graciela
Publicado: (2015)

The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson’s disease
por: Al-Hilaly, Youssra K., et al.
Publicado: (2016)

Clinical Neuropathology image 5-2014: α-synuclein pathology in the ependyma in Parkinson’s disease
por: Kovacs, Gabor
Publicado: (2014)

Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson’s disease
por: Banks, Susan M.L., et al.
Publicado: (2020)

Trojan horses and tunneling nanotubes enable α-synuclein pathology to spread in Parkinson disease
por: Rajasekaran, Santhanasabapathy, et al.
Publicado: (2021)

The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
por: García‐Sanz, Patricia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9c4l0dnk9tmpbunl86tbu8sstg